Prevention of postoperative adhesions by biodegradable cryogels from pectin and chitosan polysaccharides
Source abstract
Abstract
The main complication that may arise after surgery is the formation of adhesions. The current trend in the prevention of postoperative adhesions is the application of anti-adhesive barrier materials for the separation of wound tissue during the critical period of mesothelial repair and healing. In this work, cryogels based on pectin and chitosan were obtained by the ionic cryotropic gelation method. It was found that the Heracleum L. pectin cryogels are more elastic (73 ± 6 kPa) than the apple pectin cryogels (29 ± 11 kPa). The addition of chitosan with different physical and chemical characteristics did not significantly affect the elasticity of pectin–chitosan cryogels. The greatest swelling ability was achieved during in vivo incubation of Heracleum L. pectin cryogels and Heracleum L. pectin with reacetylated chitosan cryogels (17.1 ± 1.6 and 14.2 ± 2.0 g/g, respectively). It was found that the complete biodegradation of apple pectin cryogels occurred within 24 h of incubation in the rat abdominal cavity. Heracleum L. pectin cryogels were encapsulated in a fibrous capsule and detected in the abdominal cavity after 168 h. Maximum anti-adhesion effect was observed through the use of apple pectin cryogels (0 ± 0.5 score). Significant anti-adhesive effect was also observed through the use of apple pectin–reacetylated chitosan cryogels (1 ± 0.5 score). Due to the high anti-adhesive activity, such cryogels can be recommended for the development of a new barrier material for use in surgery. The potential anti-adhesive mechanism of apple pectin cryogels which may be attributed to a combination of barrier function and bioactivity of cryogels components was discussed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Intestinal and Peritoneal Adhesions · Surgical Sutures and Adhesives · Hernia repair and management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russia
Institute of Physiology, Komi Science Centre, The Urals Branch of the Russian Academy of Sciences, Syktyvkar, Russia
Medical Institute, Syktyvkar State University, Russia
Funding
Program of UD RAS · FASIE, the program “UMNIK”
References (50)
Show source-provided references
1. Menzies D · Ann R Coll Surgeons Engl · 1990 · 72 · 60
2. 10.1016/j.carbpol.2013.09.00110.1016/j.carbpol.2013.09.001 ↗
3. 10.1067/j.cpsurg.2015.05.00110.1067/j.cpsurg.2015.05.001 ↗
4. 10.1007/s00595-004-3050-810.1007/s00595-004-3050-8 ↗
5. 10.1016/j.jss.2009.09.01510.1016/j.jss.2009.09.015 ↗
6. 10.1007/s00595-013-0608-310.1007/s00595-013-0608-3 ↗
7. 10.3748/wjg.v12.i28.457210.3748/wjg.v12.i28.4572 ↗
8. Aranaz I · Curr Chem Biol · 2009 · 3 · 203
9. Dutta PK · J Sci Ind Res · 2004 · 63 · 20
10. 10.1016/j.carbpol.2011.03.03410.1016/j.carbpol.2011.03.034 ↗
11. 10.1016/j.addr.2009.09.00410.1016/j.addr.2009.09.004 ↗
12. 10.3390/md1303113310.3390/md13031133 ↗
13. 10.1134/S106816200903001710.1134/S1068162009030017 ↗
14. 10.1016/j.ijbiomac.2010.10.00610.1016/j.ijbiomac.2010.10.006 ↗
15. 10.1016/j.ijpharm.2010.12.01510.1016/j.ijpharm.2010.12.015 ↗
16. 10.1016/j.ijbiomac.2012.07.00210.1016/j.ijbiomac.2012.07.002 ↗
17. 10.1016/j.eurpolymj.2014.09.00810.1016/j.eurpolymj.2014.09.008 ↗
18. 10.2174/138955751566615022711054710.2174/1389557515666150227110547 ↗
19. 10.1007/s10856-013-4981-710.1007/s10856-013-4981-7 ↗
20. 10.1016/j.biomaterials.2009.05.08410.1016/j.biomaterials.2009.05.084 ↗
21. 10.1016/j.msec.2015.12.08010.1016/j.msec.2015.12.080 ↗
22. 10.1016/j.carbpol.2012.02.01110.1016/j.carbpol.2012.02.011 ↗
23. 10.1016/j.ijsu.2013.09.01210.1016/j.ijsu.2013.09.012 ↗
24. Falabella CA · J Surg Res · 2008 · 7 · 1
25. 10.1016/j.carbpol.2012.06.03710.1016/j.carbpol.2012.06.037 ↗
26. 10.1016/j.biomaterials.2014.01.05010.1016/j.biomaterials.2014.01.050 ↗
27. 10.1177/088391151142356210.1177/0883911511423562 ↗
28. 10.1177/088391151663737410.1177/0883911516637374 ↗
29. Konovalova M V · Prog Chem Appl Chitin Deriv · 2016 · 114
30. 10.1134/S106193480906019710.1134/S1061934809060197 ↗
31. Shigemasa Y · 1996 · 204
32. 10.1016/0141-8130(91)90027-R10.1016/0141-8130(91)90027-R ↗
33. Vitiazev FV · Bioorg Khim · 2012 · 38 · 365
34. 10.1016/0003-2697(71)90432-510.1016/0003-2697(71)90432-5 ↗
35. 10.1007/s10856-012-4713-410.1007/s10856-012-4713-4 ↗
36. 10.1002/jbm.a.3439410.1002/jbm.a.34394 ↗
37. 10.1016/j.polymer.2015.02.00110.1016/j.polymer.2015.02.001 ↗
38. 10.1016/j.jss.2010.06.02810.1016/j.jss.2010.06.028 ↗
39. 10.1070/RC1998v067n07ABEH00039910.1070/RC1998v067n07ABEH000399 ↗
40. 10.1016/j.foodhyd.2011.09.00110.1016/j.foodhyd.2011.09.001 ↗
41. 10.1016/j.biortech.2013.02.06310.1016/j.biortech.2013.02.063 ↗
42. 10.1016/j.tibtech.2003.08.00210.1016/j.tibtech.2003.08.002 ↗
43. 10.1007/s10856-008-3504-410.1007/s10856-008-3504-4 ↗
44. 10.1007/s10856-010-4124-310.1007/s10856-010-4124-3 ↗
45. 10.1016/j.ijbiomac.2014.09.04010.1016/j.ijbiomac.2014.09.040 ↗
46. 10.1182/blood-2008-11-19144510.1182/blood-2008-11-191445 ↗
47. 10.1021/bm010008g10.1021/bm010008g ↗
48. 10.1016/j.msec.2015.03.02710.1016/j.msec.2015.03.027 ↗
49. 10.1016/j.smim.2007.11.00410.1016/j.smim.2007.11.004 ↗
50. 10.1016/j.ejpb.2015.08.00410.1016/j.ejpb.2015.08.004 ↗